Prognostic value of Caspase-3 expression in cancers of digestive tract: A meta-analysis and systematic review

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 7, 2015, Pages 10225-10234

  Chen, Hao ^a   Yang, Xia ^a   Feng, Zhenbo ^a   Tang, Ruixue ^a   Ren, Fanghui ^a   Wei, Kanglai ^a   Chen, Gang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Caspase 3; Digestive tract cancers; Immunohistochemistry; Meta analysis; Prognosis; Systematic review

Indexed keywords

CASPASE 3;

CANCER PROGNOSIS; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; META ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW;

EID: 84940640221     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Nikolopoulos D, Theocharis S and Kouraklis G. Ghrelin’s role on gastrointestinal tract cancer. Surg Oncol 2010; 19: e2-e10.
2. Li R, Chen WC, Pang XQ, Tian WY, Wang WP, Zhang XG. Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer. Mol Biol Rep 2012; 39: 8755-8761.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
4. Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y. Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol 2003; 9: 1415-1420.
5. Kumar S. The apoptotic cysteine protease CPP32. Int J Biochem Cell Biol 1997; 29: 393-396.
6. Sternberg MJ, Bates PA, Kelley LA, MacCallum RM. Progress in protein structure prediction: assessment of CASP3. Curr Opin Struct Biol 1999; 9: 368-373.
7. Jiang H, Gong M, Cui Y, Ma K, Chang D, Wang TY. Upregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern China. Dis Esophagus 2010; 23: 487-492.
8. Hsia JY, Chen CY, Chen JT, Hsu CP, Shai SE, Yang SS, Chuang CY, Wang PY, Miaw J. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Surg Oncol 2003; 29: 44-48.
9. Cao FM, Zhang XH, Yan X, Wang JL, Xing LX, Wang XL, Shen HT, Wang FR. [Expression and prognostic significance of survivin and caspase-3 in esophageal squamous-cell carcinoma and their relationship with HSPs expression]. Zhonghua Zhong Liu Za Zhi 2005; 27: 416-419.
10. Parenti A, Leo G, Porzionato A, Zaninotto G, Rosato A, Ninfo V. Expression of survivin, p53, and caspase 3 in Barrett’s esophagus carcinogenesis. Hum Pathol 2006; 37: 16-22.
11. Isobe N, Onodera H, Mori A, Shimada Y, Yang W, Yasuda S, Fujimoto A, Ooe H, Arii S, Kitaichi M, Imamura M. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology 2004; 66: 201-209.
12. Kim MA, Lee HE, Lee HS, Yang HK, Kim WH. Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma. Virchows Arch 2011; 459: 503-510.
13. Xiao LJ, Zhao S, Zhao EH, Zheng X, Gou WF, Takano Y, Zheng HC. Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett 2013; 6: 1277-1284.
14. Li YH, Wang C, Meng K, Chen LB, Zhou XJ. Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma. World J Gastroenterol 2004; 10: 1984-1988.
15. Hector S, Conlon S, Schmid J, Dicker P, Cummins RJ, Concannon CG, Johnston PG, Kay EW, Prehn JH. Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer. Br J Cancer 2012; 106: 1499-1505.
16. Meyer A, Merkel S, Brückl W, Schellerer V, Schildberg C, Campean V, Hohenberger W, Croner RS. Cdc2 as prognostic marker in stage UICC II colon carcinomas. Eur J Cancer 2009; 45: 1466-1473.
17. Dawson H, Koelzer VH, Karamitopoulou E, Economou M, Hammer C, Muller DE, Lugli A, Zlobec I. The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome. Histopathology 2014; 64: 577-584.
18. de Oca J, Azuara D, Sanchez-Santos R, Navarro M, Capella G, Moreno V, Sola A, Hotter G, Biondo S, Osorio A, Martí-Ragué J, Rafecas A. Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. Int J Colorectal Dis 2008; 23: 21-27.
19. Guan J, Zhao R, Zhang X, Cheng Y, Guo Y, Wang L, Mi L, Liu F, Ma X, Li B. Chicken Skin Mucosa Surrounding Adult Colorectal Adenomas is a Risk Factor for Carcinogenesis. Am J Clin Oncol 2012; 35: 527-532.
20. Koelink PJ, Sier CF, Hommes DW, Lamers CB, Verspaget HW. Clinical significance of stromal apoptosis in colorectal cancer. Br J Cancer 2009; 101: 765-773.
21. Noble P, Vyas M, Al-Attar A, Durrant S, Scholefield J, Durrant L. High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival. Br J Cancer 2013; 108: 2097-2105.
22. de Heer P, de Bruin E C, Klein-Kranenbarg E, Aalbers RI, Marijnen CA, Putter H, de Bont HJ, Nagelkerke JF, van Krieken JH, Verspaget HW, van de Velde CJ, Kuppen PJ; Dutch Colorectal Cancer Group. Caspase-3 activity predicts local recurrence in rectal cancer. Clin Cancer Res 2007; 13: 5810-5815.
23. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
25. Egger M, Smith GD, Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
27. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc A 1988; 151: 419-463.
28. Kurabayashi A, Furihata M, Matsumoto M, Ohtsuki Y, Sasaguri S, Ogoshi S. Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia. Modern Pathology 2001; 14: 741-747.
29. Zhang RG, Wang CS, Gao CF. Prevalence and Pathogenesis of Barrett’s Esophagus in Luoyang, China. Asian Pac J Cancer Prev 2012; 13: 2185-2191.
30. Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 2001; 81: 681-688.
31. Sun Y, Chen XY, Liu J, Cheng XX, Wang XW, Kong QY, Li H. Differential caspase-3 expression in noncancerous, premalignant and cancer tissues of stomach and its clinical implication. Cancer Detect Prev 2006; 30: 168-173.